MyCartis NV of Zwijnaarde at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair
Service

MyCartis NV

Industriepark Zwijnaarde 7C, 9052 Zwijnaarde
Belgium

Telephone +32 9 2411164
Fax +32 9 2411169
info@mycartis.net

This company is co-exhibitor of
Flanders Investment & Trade/ Flanders Care

Hall map

MEDICA 2017 hall map (Hall 3): stand J74

Fairground map

MEDICA 2017 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems
  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems
  • 03.02.07.12  Immunoassay with particle count
  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems
  • 03.02.07.15  Luminescence immunoassay (LIA, SPALT)
  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems
  • 03.02.07.16  Luminescence-enhanced immunoenzymatic assay (LIEMA)
  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.15  Rapid tests - Immunochemistry
  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.16  Therapeutic drug monitoring
  • 03  Diagnostics
  • 03.05  Infectious Immunology
  • 03.05.08  Rapid tests - Infectious immunology

Our products

Product category: Immuno assay systems, Immunoassay with particle count, Luminescence immunoassay (LIA, SPALT), Luminescence-enhanced immunoenzymatic assay (LIEMA), Rapid tests - Immunochemistry, Therapeutic drug monitoring, Rapid tests - Infectious immunology

MyCartis technologies: accelerate innovation in biomarker analysis

MyCartis constantly develops technologies that push healthcare towards the next level of personalization. Not by ourselves, but by being part of a bigger network where we share ideas, knowledge and expertise. This allows us to accelerate innovation.

More Less

Product category: Immuno assay systems, Immunoassay with particle count, Luminescence immunoassay (LIA, SPALT), Luminescence-enhanced immunoenzymatic assay (LIEMA), Rapid tests - Immunochemistry, Therapeutic drug monitoring, Rapid tests - Infectious immunology

MyCartis applications: improve bioassays

MyCartis is committed to provide disruptive solutions in the fields of clinical and translational research for its customers and partners. By making biomarker assays simpler and faster, healthcare is already becoming more personalised.

More Less

About us

Company details

About MyCartis
Biomarker analysis made fast and easy

The big revolution in healthcare today is that we are finally realizing that we are all equal, but not identical, certainly not at a molecular level.

MyCartis’ goal is to deliver innovative solutions for fast and cost effective identification of a patient’s specific signature of biomarkers. On our road to validate biomarkers on a larger scale, our intention is to build a bridge between research and medical practice by developing broadly available multiplexed biomarker solutions through technology (Evalution™) and bio-assays. The new multiplexing solution Evalution provides a ‘one technology fits all’ solution to enable researchers and assay developers to validate their biomarkers and to utilize and commercialize them. Evalution now provides anyone the opportunity to build multiplex assays for their biomarkers and to easily measure them in a fast, accurate and robust way.

The MyCartis technology jumps in exactly there where most biomarker programs end.

More Less